BioSpace News Archive

Genetown

Nimbus Therapeutics Announces $65 Million in New Financing to Accelerate Pipeline Progress and Expand Discovery Efforts

New capital to accelerate the company’s pipeline progress and fuel its expansion into new high-value targets aimed at overlapping biological mechanisms in immunology, oncology and metabolic disease

June 5, 2018
·
4 min read
Biotech Beach

Stand Up To Cancer to Return on Friday, September 7 for Sixth Star-Studded Roadblock Telecast

The entertainment community is coming together for Stand Up To Cancer (SU2C) and its sixth biennial roadblock televised fundraising special, supporting urgently needed research and new treatments for cancer.

June 5, 2018
·
13 min read
Deals

Concord Medical Announces Agreement to Sell Equity Interest in Beijing Allcure Medical Information Technology Ltd

Concord Medical Services Holdings Limited announced that Beijing Concord Medical Technology Co., Ltd, a subsidiary of Concord Medical, entered into an equity interest transfer agreement with Tibet Allcure Information Technology Ltd.

June 5, 2018
·
2 min read
Deals

GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding Shares

GT Biopharma Inc. announces that the officers, non-independent directors of the Company and a significant founding shareholder of GT Biopharma’s predecessor companies have entered into lock-up agreements.

June 5, 2018
·
3 min read
Pharm Country

Children with Complex Movement Disorders See Improvement after Treatment with Tikun Olam’s Avidekel™ Medical Cannabis Strain, New Study Shows

Children with Complex Movement Disorders (CMD) see a “significant” improvement after treatment with medical cannabis, a new study using Tikun Olam’s high-CBD, low -THC Avidekel™ strain confirms.

June 5, 2018
·
2 min read
Policy

Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy

Audentes Therapeutics, Inc. announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM).

June 5, 2018
·
4 min read
Pharm Country

Certara Launches Version 8.1 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software; Introduces Professional Certification Program

Certara® announced the launch of Phoenix® 8.1.

June 5, 2018
·
6 min read
BioCapital

CEL-SCI to Present Today at the 8th Annual LD Micro Invitational

CEL-SCI Corporation announced that Geert Kersten, Chief Executive Officer, will be presenting today, June 5, 2018 at 12:00 pm PT / 3:00 pm ET at the 8th annual LD Micro Invitational.

June 5, 2018
·
1 min read
BioCapital

Students Honored in Washington, D.C. as Winners in World’s Largest K-12 Science Competition

Students from across the United States will travel this week to Washington, D.C., where they will be recognized as national winners of the 26th annual ExploraVision program, the world’s largest K-12 science competition.

June 5, 2018
·
6 min read
Business

Sosei Announces Appointment of Chris Cargill as Interim CFO

Sosei Group Corporation announces that Mr. Andrew Oakley, Executive Vice President and CFO, has resigned from the Company.

June 5, 2018
·
2 min read